Economic burden of illness imposed by severe sepsis in Austria
- PMID: 12602114
Economic burden of illness imposed by severe sepsis in Austria
Abstract
Introduction: Sepsis is a life-threatening disease, requiring instant treatment in an intensive care unit (ICU). The aim of this study was to determine the direct and indirect costs occurring in Austria due to this disease.
Patients and methods: Direct costs were calculated based on a retrospective chart analysis in four adult Austrian ICUs, evaluating 74 patient records from the years 2000/2001. Patients were identified to have suffered from severe sepsis using ACCP-definitions. Assessed resource use (medication, laboratory analysis, microbiology analysis, consumer-goods, diagnostic procedures, staff costs, and basic bed costs) was linked with related center specific costs to determine direct costs per patient. Indirect costs due to productivity losses were calculated using official statistical material.
Results: The mean length of ICU stay (LOS ICU) of a severely septic patient was 18.1 days. Overall ICU mortality was found to be 43.2% and showed no gender difference. The mean daily direct ICU costs of care for severely septic patients were [symbol: see text] 1,617 and the mean total direct ICU costs per septic patient were [symbol: see text] 28,582. In total costs, survivors were equally expensive as non-survivors ([symbol: see text] 28,699 vs. 28,463) although their length of study was considerably longer (21.9 vs. 13.2 days). Considering a range of patients with severe sepsis in Austria from 6,700 to 9,500 per year, total direct costs in Austria range from [symbol: see text] 192 million to [symbol: see text] 272 million. Indirect costs determined by productivity losses due to unfitness for work (temporary and permanent) and premature death amount to [symbol: see text] 484 million to [symbol: see text] 686 million in Austria per year (same incidence range). Total costs, i.e. burden of illness, combining direct costs with indirect costs, range from [symbol: see text] 676 million to [symbol: see text] 958 million.
Conclusion: Patients with severe sepsis have a high mortality rate, spend prolonged periods of time in the ICU, and are expensive to treat. Indirect costs of severe sepsis due to productivity losses, particularly by premature death, are considerable.
Comment in
-
Perspectives in economic analyses of sepsis.Wien Klin Wochenschr. 2002 Aug 30;114(15-16):660-2. Wien Klin Wochenschr. 2002. PMID: 12602108 No abstract available.
Similar articles
-
[Sepsis, a complicated syndrome with major medical and social consequences].Ned Tijdschr Geneeskd. 2004 May 15;148(20):975-8. Ned Tijdschr Geneeskd. 2004. PMID: 15181721 Review. Dutch.
-
Primary sepsis in a university hospital in northern Sweden: a retrospective study.Acta Anaesthesiol Scand. 2004 Sep;48(8):960-7. doi: 10.1111/j.0001-5172.2004.00458.x. Acta Anaesthesiol Scand. 2004. PMID: 15315612
-
[Approximation to the cost of pharmacological treatment of rheumatoid arthritis in Spain].An Med Interna. 2003 Mar;20(3):114-21. An Med Interna. 2003. PMID: 12756895 Spanish.
-
Burden of illness imposed by severe sepsis in Germany.Eur J Health Econ. 2002;3(2):77-82. doi: 10.1007/s10198-002-0095-8. Eur J Health Econ. 2002. PMID: 15609133
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
Cited by
-
Drotrecogin alfa (activated): a pharmacoeconomic review of its use in severe sepsis.Pharmacoeconomics. 2004;22(7):445-76. doi: 10.2165/00019053-200422070-00004. Pharmacoeconomics. 2004. PMID: 15137883 Review.
-
[The cost of sepsis].Anaesthesist. 2006 Jun;55 Suppl 1:36-42. doi: 10.1007/s00101-006-1039-y. Anaesthesist. 2006. PMID: 16685555 Review. German.
-
Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013.World J Urol. 2016 Aug;34(8):1193-200. doi: 10.1007/s00345-015-1722-1. Epub 2015 Dec 11. World J Urol. 2016. PMID: 26658886 Free PMC article.
-
Societal costs of sepsis in the Netherlands.Crit Care. 2024 Jan 22;28(1):29. doi: 10.1186/s13054-024-04816-3. Crit Care. 2024. PMID: 38254226 Free PMC article.
-
Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?Front Public Health. 2022 Oct 14;10:969395. doi: 10.3389/fpubh.2022.969395. eCollection 2022. Front Public Health. 2022. PMID: 36311594 Free PMC article.